These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1336316

  • 1. cAMP and extrarenal vasopressin V2 receptors in dogs.
    Liard JF.
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1888-91. PubMed ID: 1336316
    [Abstract] [Full Text] [Related]

  • 2. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
    Liard JF.
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H99-106. PubMed ID: 8304528
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF.
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of the receptors which mediate the stimulation of ACTH secretion by vasopressin in conscious dogs.
    Schwartz J, Reid IA.
    Neuroendocrinology; 1986 Feb; 42(2):93-6. PubMed ID: 3005898
    [Abstract] [Full Text] [Related]

  • 6. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF.
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [Abstract] [Full Text] [Related]

  • 7. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A, Siga E, Vassent G, Imbert-Teboul M.
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [Abstract] [Full Text] [Related]

  • 8. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A, Hoffmann P, Dumas A, Serradeil-le Gal C, Raufaste D, Herbert JM.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs.
    Liard JF.
    Circ Res; 1986 May; 58(5):631-40. PubMed ID: 3754791
    [Abstract] [Full Text] [Related]

  • 10. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
    Kaufmann JE, Oksche A, Wollheim CB, Günther G, Rosenthal W, Vischer UM.
    J Clin Invest; 2000 Jul; 106(1):107-16. PubMed ID: 10880054
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN.
    N Engl J Med; 1988 Apr 07; 318(14):881-7. PubMed ID: 2965301
    [Abstract] [Full Text] [Related]

  • 12. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS, Derkx FH, Boomsma F, Brommer EJ, Schalekamp MA.
    Neth J Med; 1993 Aug 07; 43(1-2):5-12. PubMed ID: 8232694
    [Abstract] [Full Text] [Related]

  • 13. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW, North WG.
    Brain Res; 1989 Feb 06; 479(1):35-9. PubMed ID: 2522339
    [Abstract] [Full Text] [Related]

  • 14. V1 vs. combined V1+V2 vasopressin blockade after hemorrhage in conscious dogs.
    Liard JF.
    Am J Physiol; 1988 Dec 06; 255(6 Pt 2):H1325-9. PubMed ID: 2974249
    [Abstract] [Full Text] [Related]

  • 15. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG, Ross MG, Leake RD, Fisher DA.
    Am J Physiol; 1992 Apr 06; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [Abstract] [Full Text] [Related]

  • 16. Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system.
    Brooks VL, Hatton DC.
    Am J Physiol; 1991 Jun 06; 260(6 Pt 2):H1878-87. PubMed ID: 1829332
    [Abstract] [Full Text] [Related]

  • 17. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M, Tahara A, Sugimoto T.
    Biochem Pharmacol; 1997 Jun 01; 53(11):1711-7. PubMed ID: 9264324
    [Abstract] [Full Text] [Related]

  • 18. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH, Man in 't Veld AJ, Jones R, Reid JL, Schalekamp MA.
    J Hypertens Suppl; 1983 Dec 01; 1(2):58-61. PubMed ID: 6400119
    [Abstract] [Full Text] [Related]

  • 19. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
    Bichet DG, Razi M, Arthus MF, Lonergan M, Tittley P, Smiley RK, Rock G, Hirsch DJ.
    Kidney Int; 1989 Nov 01; 36(5):859-66. PubMed ID: 2559238
    [Abstract] [Full Text] [Related]

  • 20. Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate.
    Luk J, Ajaelo I, Wong V, Wong J, Chang D, Chou L, Reid IA.
    Am J Physiol; 1993 Sep 01; 265(3 Pt 2):R524-9. PubMed ID: 8214142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.